Mendelian Reverse Cholesterol Transport Study

Summary

The purpose of this study is to investigate the use of radiolabeled particulate cholesterol administered intravenously in association with albumin, as a method to study reverse cholesterol transport (RCT) in people carrying mutations in genes known to affect high density lipoprotein (HDL) metabolism by analyzing changes in the tracer activity in total plasma, lipoproteins fractions and feces.

Timeline

Start

2012-10

Primary completion

2024-09-04

Completion

2024-09-04

Outcome

Outcome not reported

Stopped (Business): “Lack of funding”

Drugs

Indications